Treating Neonatal Sepsis In Uganda Gardp By ticking the box you confirm you agree to hearing from gardp. we will use the information you provide with this form to email you updates on our work. you can change your mind at any time by clicking the unsubscribe link in the footer of any email newsletter you receive from us, or by contacting us at [email protected] . From 2018 2020, gardp and partners carried out a global observational study of over 3200 newborns with sepsis at 19 hospitals in 11 countries, including at the mulango specialized women and neonatal hospital in uganda. results from the study have been used to design an upcoming trial of combination treatment regimens for newborns with sepsis.
Lifesaving Treatment For Neonatal Sepsis In Uganda Gardp Orum mukasa and his mother prudence nakato at their home in kigo, kampala, uganda. ***. from 2018 2020, gardp and partners carried out an observational study of neonatal sepsis at 19 hospitals in 11 countries, including uganda. gardp has now launched a neonatal sepsis trial in south africa and kenya to test the safety and effectiveness of three. Saving childrens’ lives – treating neonatal sepsis speaker(s), moderator: hanan balkhy, manica balasegaram, dhanya dharmapalan & borna nyaoke, peter beyer (moderator). The recommended first line treatment of neonatal sepsis in uganda is administration of intravenous ampicillin and gentamycin and cephalosporins as second line drugs (2, 13). worryingly, despite new born health interventions, neonatal mortality rate (nmr) persisted at approximately 27 1,000 live births between 2002 and 2016, according to three. In africa, gardp is currently conducting clinical trials and studies on neonatal sepsis in eastern africa (kenya and uganda) and south africa. countries like nigeria in west africa with high incidences of neonatal sepsis would be good collaborating partners in our amr work as the programmes expand.
Comments are closed.